$704 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 32 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PACB | Exit | PACIFIC BIOSCIENCES CALIF INcall | $0 | – | -43,700 | -100.0% | -0.01% | – |
| AGEN | Exit | AGENUS INCcall | $0 | – | -100,000 | -100.0% | -0.01% | – |
| PFE | Exit | PFIZER INCcall | $0 | – | -750,000 | -100.0% | -0.01% | – |
| OPK | Exit | OPKO HEALTH INCcall | $0 | – | -473,800 | -100.0% | -0.02% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -0.02% | – |
| SEM | Exit | SELECT MED HLDGS CORPcall | $0 | – | -26,100 | -100.0% | -0.02% | – |
| XBIT | Exit | XBIOTECH INC | $0 | – | -350,000 | -100.0% | -0.03% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INCcall | $0 | – | -63,000 | -100.0% | -0.05% | – |
| VTNR | Exit | VERTEX ENERGY INC | $0 | – | -90,000 | -100.0% | -0.06% | – |
| LLY | Exit | LILLY ELI & COcall | $0 | – | -100,000 | -100.0% | -0.08% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -300,000 | -100.0% | -0.11% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INCcall | $0 | – | -383,700 | -100.0% | -0.15% | – |
| BDSX | Exit | BIODESIX INC | $0 | – | -180,833 | -100.0% | -0.18% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -80,000 | -100.0% | -0.27% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -38,500 | -100.0% | -0.38% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -838,403 | -100.0% | -0.53% | – |
| SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -149,678 | -100.0% | -0.67% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -70,000 | -100.0% | -1.09% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -315,642 | -100.0% | -1.12% | – |
| AVIR | Exit | ATEA PHARMACEUTICALS INC | $0 | – | -309,126 | -100.0% | -1.35% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.